Tower Research Capital (TRC)’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.63K Sell
2,804
-1,492
-35% -$2.46K ﹤0.01% 4289
2025
Q1
$6.79K Buy
4,296
+2,910
+210% +$4.6K ﹤0.01% 4012
2024
Q4
$4.64K Sell
1,386
-823
-37% -$2.76K ﹤0.01% 4427
2024
Q3
$4.15K Sell
2,209
-1,174
-35% -$2.21K ﹤0.01% 4655
2024
Q2
$6.67K Buy
3,383
+2,142
+173% +$4.22K ﹤0.01% 4553
2024
Q1
$3.81K Buy
1,241
+451
+57% +$1.39K ﹤0.01% 4786
2023
Q4
$1.84K Buy
790
+521
+194% +$1.21K ﹤0.01% 5311
2023
Q3
$1.09K Buy
+269
New +$1.09K ﹤0.01% 5406
2023
Q2
Sell
-115
Closed 6363
2023
Q1
$0 Sell
115
-1,319
-92% ﹤0.01% 6325
2022
Q4
$4K Sell
1,434
-82
-5% -$229 ﹤0.01% 5078
2022
Q3
$6K Buy
1,516
+850
+128% +$3.36K ﹤0.01% 5068
2022
Q2
$5K Buy
666
+242
+57% +$1.82K ﹤0.01% 5111
2022
Q1
$5K Sell
424
-39
-8% -$460 ﹤0.01% 5119
2021
Q4
$8K Buy
463
+160
+53% +$2.77K ﹤0.01% 4834
2021
Q3
$7K Buy
303
+86
+40% +$1.99K ﹤0.01% 4680
2021
Q2
$14K Sell
217
-18
-8% -$1.16K ﹤0.01% 4194
2021
Q1
$29K Sell
235
-237
-50% -$29.2K ﹤0.01% 3590
2020
Q4
$53K Sell
472
-1,172
-71% -$132K ﹤0.01% 3078
2020
Q3
$196K Buy
1,644
+1,438
+698% +$171K ﹤0.01% 2597
2020
Q2
$26K Buy
206
+94
+84% +$11.9K ﹤0.01% 3547
2020
Q1
$22K Buy
112
+108
+2,700% +$21.2K ﹤0.01% 1675
2019
Q4
$1K Sell
4
-66
-94% -$16.5K ﹤0.01% 3334
2019
Q3
$23K Buy
70
+51
+268% +$16.8K ﹤0.01% 2385
2019
Q2
$8K Sell
19
-17
-47% -$7.16K ﹤0.01% 2717
2019
Q1
$21K Sell
36
-112
-76% -$65.3K ﹤0.01% 2250
2018
Q4
$44K Buy
+148
New +$44K ﹤0.01% 1370
2018
Q3
Sell
-13
Closed -$8K 4292
2018
Q2
$8K Buy
+13
New +$8K ﹤0.01% 2901